Patent Scalable

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

PatentsGlobal

Kolon Life Science Secures Canadian Patent for Scalable Oncolytic Virus Manufacturing Process

Kolon Life Science has obtained a Canadian patent allowance for its innovative large-scale production method of KLS-3021, an oncolytic virus candidate targeting solid tumors. This patent enhances the company’s intellectual property assets across key markets including South Korea, the US, Europe, and China, supporting…

Wednesday, June 10, 2026

Newsletters & Digests

Follow Patent Scalable

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Explore

All newsroom coverage Filtered archive